Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
2019
Background
Psychostimulants and atomoxetine have been shown to increase blood pressure, heart rate, and QT interval in children and adolescents; however, based on current literature, it is unclear if these “attention-deficit/hyperactivity disorder (ADHD) medications” are also associated with serious cardiovascular (SCV) events. We addressed this question in commonly exposed groups of children and adolescents with either ADHD or autism spectrum disorder (ASD).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
47
References
3
Citations
NaN
KQI